Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar

[1]  P. Asfar.  Terlipressin in chronic hyperdynamic endotoxic shock: is it safe? , 2003, Intensive Care Medicine.

[2]  M. Singer,et al.  Terlipressin for norepinephrine-resistant septic shock , 2002, The Lancet.

[3]  Haruhiko Yamada,et al.  Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock , 2001, Critical care medicine.

[4]  P. Coriat,et al.  Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. , 1999, Anesthesia and analgesia.

[5]  H. Bruining,et al.  Vasopressin deficiency contributes to the vasodilation of septic shock. , 1998, Circulation.

[6]  I. Pávó,et al.  Aggressive role of vasopressin in development of different gastric lesions in rats. , 1994, European journal of pharmacology.

[7]  S. Vatner,et al.  Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. , 1976, The American journal of physiology.

[8]  S. Rittig,et al.  The hemodynamic effects of triglycyl‐lysine‐vasopressin (glypressin) in patients with parkinsonism and orthostatic hypotension , 1991, Movement disorders : official journal of the Movement Disorder Society.

[9]  C. F. Schaefer,et al.  Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. , 1985, Circulatory shock.